Assessment of Pharmacokinetic Similarity of FYB206 in Comparison with Keytruda in Resected Stage II or Stage III Melanoma Patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509765-20-00

Acronym

FYB206-C1-01

Enrollment

116

Registered

2024-08-28

Start date

2024-10-21

Completion date

Unknown

Last updated

2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IIC, Melanoma: Adjuvant treatment of patients with Stage IIB, or III melanoma following complete resection

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Estonia, Lithuania, Poland, Romania

None listed

Source: EU CTIS · Data processed: Feb 4, 2026